InsideOut Institute Logo
Log inAre you at risk?
eClinic
Our world-first eClinic is here. Free, trusted eating disorder support now available anytime, anywhere. No referral. No cost. Backed by experts, built for you.
Projects
/

Panorexia: A clinical trial of psilocybin-assisted psychotherapy for treatment-resistant Anorexia Nervosa

PROJECT

Panorexia: A clinical trial of psilocybin-assisted psychotherapy for treatment-resistant Anorexia Nervosa

clinical
Inside Out Logo

This trial evaluates the safety, feasibility, and preliminary efficacy of psilocybin-assisted psychotherapy for individuals with treatment-resistant anorexia nervosa who have not responded to standard evidence-based interventions.

Aims
This clinical trial, in collaboration with Imperial College London, aims to assess the safety, feasibility, mechanism of change, and preliminary efficacy of psilocybin-assisted psychotherapy in individuals with treatment-resistant Anorexia Nervosa (AN). This study has the potential to offer a transformative new treatment option for individuals with long-standing, treatment-resistant AN.

Background
AN is a severe psychiatric illness characterised by extreme malnutrition and high treatment resistance. Current interventions targeting core features—such as fear of weight gain and ritualised behaviours—are often ineffective, with dropout rates of 20–50% in inpatient care and up to 70% in outpatient settings. If left untreated, 20–30% of individuals develop a chronic, life-long form of AN with very limited, often invasive, treatment options. There is an urgent need for innovative therapies that can improve outcomes in this hard-to-treat population. By exploring psilocybin-assisted psychotherapy, the trial seeks to reduce core eating disorder symptoms, enhance motivation for recovery, and lay the groundwork for future, more effective interventions.

Recruitment now open: panorexia.study@sydney.edu.au

Team Members Involved
SarahRodan

Sarah Rodan

PhD Researcher/Research Assistant
Janice Russell

Professor Janice Russell

Advisory
Kristi Griffiths

Kristi Griffiths

Acting Research Stream Lead & Senior Research Fellow
Professor Sarah Maguire

Professor Sarah Maguire

Director of IOI
Publications related to this project

Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED–FED survey

Rodan, S.C., Meez, N., Lloyd-Hurwitz, S., Bedoya-Pérez, M.A., Suraev, A., Sommer, N., Greenstien, K., Maguire, S. & McGregor, I.S.

Journal of Eating Disorders.

13(1), p.152.

View Article

Prescription and Nonprescription Drug Use Among People With Eating Disorders

Rodan, S.C., Maguire, S., Meez, N., Greenstien, K., Zartarian, G., Mills, K.L., Suraev, A., Bedoya-Pérez, M.A. & McGregor, I.S.

JAMA Network Open.

8(7), e2522406.

View Article

Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa

Rodan, S. C., Aouad, P., McGregor, I. S., & Maguire, S.

OBM Neurobiology.

5(2), 1-25.

View Article
InsideOut Institute LogoAccreditation icon

Subscribe to our newsletter!

© 2026 InsideOut

InsideOut acknowledges the tradition of custodianship and law of the Country on which the University of Sydney and Charles Perkins Centre campus stands. We pay our respects to those who have cared and continue to care for Country. We are committed to diversifying research and eliminating inequities and discrimination in healthcare. We welcome all people regardless of age, gender, race, size, sexuality, language, socioeconomic status, location or ability.

Panorexia: A clinical trial of psilocybin-assisted psychotherapy for treatment-resistant Anorexia Nervosa – InsideOut Institute